Yuan-Peng Wu Ji-Jin Wu Shu-Mei Tian Tao Jin Chan Li Ke Xie
10.1097/MD.0000000000013924
Medicine (Baltimore)
2019 Jan;98(1):e13924.
CC BY
https://pubmed.ncbi.nlm.nih.gov/30608421/
Carcinoma, Non-Small-Cell Lung / drug therapy Carcinoma, Non-Small-Cell Lung / genetics ErbB Receptors / antagonists & inhibitors Erlotinib Hydrochloride / therapeutic use Pyridines / therapeutic use
Carcinoma, Non-Small-Cell Lung / drug therapy Carcinoma, Non-Small-Cell Lung / genetics ErbB Receptors / antagonists & inhibitors Erlotinib Hydrochloride / therapeutic use Pyridines / therapeutic use Case Reports Aged Carcinoma, Non-Small-Cell Lung / pathology Erlotinib Hydrochloride / administration & dosage Female Humans Karnofsky Performance Status Protein Kinase Inhibitors / administration & dosage Protein Kinase Inhibitors / therapeutic use Pyridines / administration & dosage Treatment Outcome Protein Kinase Inhibitors Pyridines apatinib Erlotinib Hydrochloride EGFR protein, human ErbB Receptors
PMC6344168
30608421
Apatinib with EGFR-TKIs in advanced wild gene-type NSCLC: A case report
2019